drugset / Trial / NCT00415116

Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors

NCT00415116 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Lenalidomide may stop the growth of solid tumors by blocking blood flow to the tumor. Drugs used in chemotherapy, such as docetaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving lenalidomide together with docetaxel and carboplatin may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of lenalidomide when given together with docetaxel and carboplatin in treating patients with advanced solid tumors.

Timeline

Start
2004-08
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lenalidomide Other / unclassified — Oral
Background Carboplatin Small molecule — Intravenous
Background Docetaxel Small molecule — Intravenous